Fish Oil Supplementation Reduces Cardiovascular Events in Hemodialysis: Results from a Multicenter RCT

A double-blind, randomized controlled trial across 26 sites found that daily n-3 fatty acid (fish oil) supplementation significantly lowered the risk of serious cardiovascular events in hemodialysis patients, with a favorable safety profile.

NephroResource

Taking longer than expected

If you're on a slow connection or this keeps happening, tap below to reload.